Polypen (Ampicillin)

Quick links to important sections

Polypen (Ampicillin)

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Polypen (Ampicillin)

Quick Facts

Property Description
Active Ingredient Ampicillin (alpha-aminobenzylpenicillin)
Pharmacological Class Broad-spectrum beta-Lactam Antibiotic (Aminopenicillin)
Origin Semi-synthetic
Common Use Elimination of systemic bacterial infections
Available Forms Capsule, Oral Suspension, Powder for Injection

Polypen is the trade name for the prescription-only medication whose active component is Ampicillin. It is classified as an aminopenicillin, placing it within the larger beta-lactam antibiotic family. This drug is clinically recognized for its established efficacy against susceptible pathogens.


What Type of Medicine is Polypen (Ampicillin)?

Polypen is an antibiotic belonging to the aminopenicillin subclass, which immediately identifies its core purpose as fighting a broad range of infectious bacteria. The key feature of this subclass is its broad-spectrum capability, achieved through chemical modification of the penicillin nucleus. This allows it to act against a wider array of bacteria compared to earlier penicillins, making it suitable for managing infections where the causative organism may not yet be precisely identified. This versatility underscores Ampicillin's enduring role in anti-infective therapy.


Active Ingredient and Available Forms

The active component of Polypen is the single-component product Ampicillin, which serves as a potent bactericidal agent. Polypen is provided in various dosage forms to accommodate different patient needs. These include oral preparations, such as capsules and liquid oral suspension, and a sterile powder for injection intended for parenteral administration (intramuscularly or intravenously) in clinical settings. This range of forms ensures the drug can be administered effectively, whether for convenient outpatient care or critical, high-systemic level treatment.


General Purpose and Bactericidal Action

The general purpose of Polypen is to eliminate systemic bacterial infections throughout the body. Ampicillin achieves this by selectively disrupting the structural integrity of the bacterial cell wall, a crucial component that is absent in human cells. By interfering with the construction process, the drug causes the bacteria to die, thereby resolving the infectious process.

Regulatory References

  1. World Health Organization Model List of Essential Medicines

What side effects are possible with Polypen (Ampicillin)?

Possible Side Effects and Safety Information

Polypen (Ampicillin) is associated with adverse reactions primarily related to hypersensitivity and the gastrointestinal system. Monitoring of patients for several key serious adverse events is a mandatory safety consideration.

Serious and Clinically Significant Reactions

  • Hypersensitivity Reactions: Serious and occasionally fatal anaphylactic reactions have been reported with penicillin therapy and require immediate emergency intervention. Ampicillin is contraindicated in patients with a history of allergy to any penicillin.
  • Clostridium difficile-associated Diarrhea (CDAD): Diarrhea that is watery or bloody, which may occur during or up to two months after therapy, can signify CDAD, a condition ranging from mild to fatal colitis.
  • Skin Reactions: Severe dermatological reactions, including Stevens-Johnson syndrome and Toxic Epidermal Necrolysis, have been reported.
  • Nervous System Effects: Seizures have been documented, particularly in patients with kidney dysfunction or high serum drug levels.
  • Hematologic Effects: Blood disorders such as anemia, thrombocytopenia, and agranulocytosis have been reported; these are generally reversible upon stopping treatment.

Common and Other Adverse Reactions

Commonly reported side effects often involve the gastrointestinal tract, including diarrhea, nausea, and vomiting. Skin rash is also a frequent occurrence. Other reactions include inflammation of the mouth and tongue (glossitis, stomatitis) and localized reactions at the injection site (phlebitis, pain).

Safety Restrictions and Precautions

  • Infectious Mononucleosis: Ampicillin is not recommended for patients with infectious mononucleosis due to a high incidence of rash.
  • Renal/Hepatic Function: For prolonged therapy, periodic assessment of renal, hepatic, and hematopoietic function is advisable.
  • Drug Interactions: Ampicillin may decrease the effectiveness of hormonal contraceptives. Concurrent use of allopurinol is associated with an increased risk of skin rash.
  • Pregnancy: The drug is generally considered Pregnancy Category B, to be used during pregnancy only if clearly needed. It is excreted into breast milk, and the infant should be monitored for gastrointestinal flora changes.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile for Ampicillin based on specific risks and mandated emergency actions. Overdosage may lead to neurological adverse effects, including convulsive seizures, myoclonus, and a depressed state of consciousness. These CNS adverse effects are strongly linked to high concentrations of the drug in the body, particularly in patients with renal function impairment. Gastrointestinal effects, such as nausea, vomiting, and diarrhea, may also be present.


Required Emergency Actions

Overdose Scenario Mandated Regulatory Action
Serious Symptoms Seek medical help right away, call 911, or contact a Poison Control Center for seizure, collapse, or trouble breathing.
Anaphylaxis Immediate emergency treatment is required for serious and potentially fatal hypersensitivity (anaphylactoid) reactions.

Official Management Procedures

In the event of acute over-exposure, regulatory guidance requires discontinuation of the medication immediately. Management consists of symptomatic treatment and the institution of supportive measures as clinically required. For anaphylactoid reactions, epinephrine, oxygen, intravenous steroids, and airway management are mandated procedures. Ampicillin can be removed by hemodialysis in patients experiencing renal function impairment.

Therapeutic Uses of Polypen (Ampicillin)

Quick Facts: Uses of Polypen (Ampicillin)

Condition Type Scope of Action
Bacterial Infections May help manage infections of the respiratory tract, urinary tract, and gastrointestinal tract.
Specific Conditions May be used to address certain cases of bacterial meningitis, septicemia (blood infection), and endocarditis (heart infection).

Polypen (Ampicillin) is an antibacterial agent used to treat a variety of infections caused by susceptible bacteria. This medication may help manage infections occurring in different parts of the body, including the lungs and other components of the respiratory tract, the kidneys and bladder of the urinary tract, and the gastrointestinal tract.

Ampicillin may also be administered to address more serious conditions, such as certain forms of bacterial meningitis (infection around the brain and spinal cord), septicemia (bloodstream infection), and endocarditis (infection of the heart lining or valves).

Ampicillin functions to stop the growth of bacteria, supporting the management of the underlying infection. It is important to note that this agent is intended only for bacterial infections and is not effective against viral infections like the common cold or flu.

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Polypen (Ampicillin)

Official regulatory documents define specific populations who must not use Ampicillin and others who require restricted or conditional use.

Contraindicated Populations Key Eligibility Restrictions
Individuals with a history of hypersensitivity or serious allergic reaction to any penicillin or other beta-lactam antibacterial agent. Renal Impairment: Use is restricted and requires mandatory dose adjustment based on creatinine clearance to prevent drug accumulation and potential neurotoxicity.
Patients with Infectious Mononucleosis or lymphatic leukemia (due to high risk of developing a non-allergic generalized skin rash). Pregnancy/Lactation: Classified as FDA Category B / TGA Category A. Use is conditional on a clear need where benefit outweighs potential risk. It is excreted in breast milk, warranting infant monitoring.
Infections caused by organisms known to be penicillinase-producing (resistant bacteria), as Ampicillin will be ineffective. Pediatrics: Safety and efficacy for the oral treatment of gonorrhea have not been established in pediatric patients weighing less than 20 kg.

Eligibility for use is otherwise established for patients without these contraindications, provided the infection is proven or strongly suspected to be caused by a susceptible bacterial organism. Use is also cautioned in older adults due to the likelihood of decreased kidney function.

What should I know about interactions with other medicines?

Polypen (Ampicillin) Interactions with other medicines and products

Ampicillin's official interaction profile details several required administration constraints and co-administration restrictions documented in regulatory labeling.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance Officially Documented Outcome
Probenecid Increases and prolongs Ampicillin blood levels by reducing the excretion of Ampicillin.
Allopurinol Substantially increases the incidence of skin rashes in patients receiving both drugs.
Bacteriostatic Antibiotics May interfere with the bactericidal effect of Ampicillin (e.g., tetracyclines, chloramphenicol, sulfonamides).
Oral Contraceptives May reduce the efficacy of contraceptives containing estrogen and progestin.

Administration and Procedural Constraints

Official documents outline constraints that must be observed to manage interaction risks:

  • Food: Oral Ampicillin absorption may be reduced when taken with food, requiring administration on an empty stomach (e.g., one hour before or two hours after meals).
  • Injections: Injectable Ampicillin must not be physically mixed with Aminoglycoside antibiotics in the same syringe or intravenous container, as this may result in the inactivation of the aminoglycoside.
  • Laboratory Tests: Ampicillin can cause false-positive reactions for glucose in the urine when tested using copper reduction methods (e.g., Benedict's Solution or Clinitest). Enzymatic glucose oxidase methods should be used instead.
  • Population Note: The drug's use is restricted in patients with Infectious Mononucleosis due to the high likelihood of developing a non-allergic skin rash.

Mechanism of Action

Irreversible Inhibition of Cell Wall Construction

Ampicillin's core mechanism is the covalent and irreversible inhibition of bacterial Penicillin-Binding Proteins (PBPs), a group of enzymes essential for synthesizing the structural component of the bacterial cell wall, peptidoglycan. Ampicillin's beta-lactam ring acts as an irreversible inhibitor by permanently binding to the PBP active site, which mimics the natural substrate. By blocking the final cross-linking step of peptidoglycan synthesis, the drug causes the formation of a structurally deficient cell wall. This action is selective because host cells lack the peptidoglycan structure.

Mechanism-Driven Bacterial Cell Lysis (Bactericidal Action)

This structural compromise triggers a destructive cascade that culminates in the physical death of the bacterial cell. The weak structure fails to withstand the cell's high internal osmotic pressure, leading to the rapid rupture of the cell membrane, a process known as lysis. This direct bactericidal action is the key physiological effect that underlies the drug's ability to induce lysis of susceptible bacterial cells.

Limitations by Bacterial Defense Enzymes

The mechanism is constrained by the bacterial enzyme beta-Lactamase, which acts as a chemical defense. This enzyme rapidly hydrolyzes and inactivates the beta-lactam ring of Ampicillin, preventing it from binding to the PBPs. The failure to bind functionally overrides the drug's mechanism, allowing the bacterium to maintain cell wall integrity and continue multiplication.

Dosage and Administration Information

Official Administration Guidelines

Ampicillin is administered through established methods, with the route and dose range determined by the clinical context. Approved routes include Oral administration (using capsules or suspension) and Parenteral administration (Intravenous or Intramuscular injection) for systemic delivery.


Dosing Schedule and Preparation

Instruction Detail
Route of Administration Oral, Intravenous (IV), Intramuscular (IM).
Dosing Schedule (Adults) Typically 250 mg to 500 mg per dose for oral use; up to 14 g per day for severe parenteral cases.
Frequency Must be administered in divided doses every six hours (q6h) to maintain systemic concentration.
Timing in Relation to Meals Oral forms should be taken with a full glass of water, preferably before meals or two hours after meals (on an empty stomach).
Preparation Requirements Powder for injection must be reconstituted with an appropriate diluent, such as Sterile Water for Injection, immediately prior to use.
Special Procedural Conditions The reconstituted solution for IM use must be administered within one hour due to stability constraints. IV injection should be administered slowly over 3 to 15 minutes.

Population and Duration Rules

Instruction Detail
Age-Group Rules Dosing for pediatric patients, including neonates, is weight-based and divided into multiple daily doses.
Renal Adjustment The dosing frequency must be adjusted for patients with renal impairment (e.g., CrCl < 10 mL/min requires dosing every 12 to 24 hours) to prevent drug accumulation.
Missed-Dose Rules Take a missed oral dose as soon as remembered. If it is almost time for the next scheduled dose, skip the missed dose and continue the regular schedule; do not double the dose.
Course Duration Treatment should continue for a minimum of 48 to 72 hours after the patient is asymptomatic, or for the specified duration required for the particular condition.

The guidelines establish that Polypen (Ampicillin) must be consistently delivered via the appropriate route, at precise six-hour intervals, and under specific conditions like using an empty stomach for oral absorption. These standards structure the use of the medicine by setting clear rules for dosage modification, especially for patients with reduced kidney function.

Recent Clinical Evidence

Research evidence / Overview of studies for Polypen (Ampicillin)

Evidence for use in Respiratory and Urinary Tract Infections

Research examined Polypen (Ampicillin) in studies exploring how symptoms change over time for acute infections studied in the context of the lungs, airways, kidneys, and bladder. These short-term studies measured outcomes related to physical discomfort and systemic imbalance in various populations. Studies report how symptoms evolved in the observed populations, noting patterns in the duration of symptom change and monitored organism levels.

Evidence quality varies across available studies, and data for certain groups remain insufficient. The relevance of older evidence is limited by the fact that many common infection-causing bacteria may have developed resistance to Ampicillin. Consequently, contemporary comparative evidence against current standard treatments is often lacking.

Evidence for use in Severe and Systemic Infections

Polypen was studied for severe conditions, including bloodstream infections (septicemia) and infections of the heart lining (endocarditis). Research commonly examined Ampicillin as part of a combination regimen with other agents, monitoring outcomes linked to inflammatory states and outcomes related to survival. Because of the complexity of these serious conditions, long-term outcomes are not fully established when considering Ampicillin monotherapy, and studies often describe combination treatments.

Evidence for use in Meningitis and Pregnancy-Related Infections

Research explored Ampicillin in conditions associated with acute or disruptive episodes, such as bacterial meningitis, which affects the membranes around the brain and spinal cord. Studies also monitored its use in pregnancy for specific situations like Preterm Premature Rupture of Membranes (PPROM), focusing on long-term neurological outcomes and the frequency of neonatal outcomes linked to inflammatory states. Data for certain groups, such as the long-term neurological health of children treated, remain insufficient.

Evidence Gaps and Research Limitations

Research explored Polypen's use in distinct groups like children and neonates and pregnant women, where patterns in drug exposure were monitored. However, follow-up durations were limited in many initial studies, and long-term outcomes for systemic or functional imbalance extending beyond the first few months are often scarce. A major limitation is the increasing prevalence of bacterial resistance to Ampicillin. Consequently, research findings apply only to infections caused by organisms confirmed to be susceptible to the drug. Comparative research is lacking against newer antibiotics, and the certainty remains low for outcomes monitored over extended periods.

Frequently Asked Questions (FAQ)

Common questions about Polypen (Ampicillin) (FAQ)


Q: How quickly should I expect to feel better after starting Polypen?

According to official product information, it is common to notice an improvement in symptoms early in the course of therapy. However, it is important to continue taking the medication for the full prescribed duration, even after you begin to notice an improvement.


Q: Is Polypen safe for children of all ages?

Official guidelines state that the administration of Polypen to pediatric patients, including newborns (neonates), is based on the child's weight (mg/kg/day). The required dose is a determination made by a healthcare professional. The safety and effectiveness for treating specific conditions, such as gonorrhea, have not been established in children who weigh less than 20 kg.


Q: Why is it important to finish the whole course of Polypen?

Regulatory patient counseling information emphasizes that skipping doses or not completing the full prescribed course of Polypen may decrease the treatment's overall effectiveness. This practice also increases the potential for bacteria to develop resistance to the medication.


Q: How should Polypen be stored at home?

The storage requirements for Polypen vary by form. The dry capsules or tablets should be stored at controlled room temperature, protected from excessive heat and moisture. Conversely, the liquid oral suspension must be kept in the refrigerator, and any unused portion must be discarded after 14 days, even when refrigerated.


Q: What if my symptoms don't improve after a few days on Polypen?

Official patient instructions indicate that if the symptoms of infection still persist or worsen after completing the full course of treatment, patients are advised to consult a healthcare professional.


Q: Is Polypen effective against E. coli bacteria?

Regulatory documents indicate that Ampicillin is utilized in the treatment of infections, such as certain urinary tract infections, when caused by susceptible strains of E. coli bacteria. For effective treatment, the causative bacterial strain must be confirmed to be susceptible to the drug.


Q: Are there specific vitamins or supplements that should be avoided with Polypen?

While the official regulatory labeling specifies interactions with certain prescription medicines (like Probenecid and Allopurinol), it does not typically list interactions with common vitamins. Patients are generally advised to inform their healthcare professional about all over-the-counter medicines, vitamins, minerals, and herbal products they are using.


Q: Why does Polypen sometimes require a higher frequency of dosing than other antibiotics?

Polypen (Ampicillin) is often administered in divided doses, typically every six hours, to ensure the concentration of the drug in the bloodstream remains effective against the bacteria. This frequent schedule is related to how the body processes and eliminates the drug, as Ampicillin is largely excreted unchanged through the urine and can have a short half-life.


Q: Are there any common foods or drinks that make Polypen less effective?

Official product information advises that oral forms of Polypen should be taken with water on an empty stomach, meaning either one-half hour before or two hours after meals. This is because food may reduce the absorption of ampicillin into your system, which could potentially make the medication less effective.


Q: Does Polypen cause sun sensitivity or a rash?

Skin rash is listed as a commonly reported side effect associated with Ampicillin. Official documents also mention the possibility of severe dermatological reactions. However, the regulatory label does not generally list sun sensitivity (photosensitivity) as a common or required warning.


Q: Is it normal to feel extra tired during the first few days on Polypen?

The official regulatory label lists common side effects that include gastrointestinal upset, diarrhea, nausea, and vomiting. While other nonspecific symptoms may occur, fatigue or unusual tiredness is not typically listed as one of the most frequently reported adverse reactions in the primary section of the Ampicillin label.


Q: Can Polypen affect the effectiveness of birth control pills?

Yes, official drug interaction information indicates that Polypen may reduce the effectiveness of hormonal contraceptives containing estrogen and progestin. This interaction may also result in increased breakthrough bleeding for some patients.


Q: Can Polypen cause digestive upset or diarrhea?

The most commonly reported side effects of Polypen involve the gastrointestinal tract and include general digestive upset, as well as specific reactions like diarrhea, nausea, and vomiting. Diarrhea can also sometimes be a sign of a more serious, rare condition.


Q: What happens if I accidentally miss a dose of Polypen?

The labeling for a missed oral dose generally states that it should be taken as soon as it is remembered. However, if it is almost time for your next scheduled dose, official guidance advises skipping the missed one entirely and continuing with your regular schedule. Official guidance also advises against taking a double dose to compensate for the missed one.


Q: Are headaches a known side effect of Polypen?

Headaches have been reported as an occasional side effect with drugs in the penicillin class, including Ampicillin. However, they are generally not listed among the most common adverse reactions in the main safety sections of the official product information.


Q: Can Polypen be crushed or split if the pill is too large?

The official regulatory labeling for standard Ampicillin capsules does not contain specific instructions advising patients to crush or split the pill. It is generally recommended not to alter the form of a medication unless there is a specific instruction to do so, or if a liquid formulation is being used.


Q: Does Polypen cause yeast infections?

Official precautions note that the prolonged use of any antibiotic, including Polypen, carries the risk of promoting the overgrowth of organisms not susceptible to the drug, such as fungi. This can lead to a secondary infection, often called a superinfection, which can include conditions like a yeast infection.

How should Polypen (Ampicillin) be stored and disposed of?

Storage and Disposal Requirements

Official instructions for storing and disposing of Ampicillin vary based on the drug's form, ensuring stability and safety. The dry powder for injection and capsules must be stored at controlled room temperature (20 C to 25 C), kept in the original, tightly closed container, and protected from excessive heat and moisture.

Conversely, the reconstituted liquid solution or oral suspension must be refrigerated (2 C to 8 C) and must not be frozen. The prepared oral suspension has a strict stability limit and must be discarded after 14 days even when refrigerated.

All forms must be stored out of the sight and reach of children.

For disposal, the preferred method is an official drug take-back program. If this is unavailable, the unused medicine must be removed from its container, mixed with an unappealing substance like coffee grounds or dirt, sealed in a bag or container, and placed in the household trash. The product should not be flushed down the toilet unless explicitly instructed by the product labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Polypen (Ampicillin) found in:

A-Z Index: